ERBB2 and breast cancer: The majority of the cases was HER2/neu type of mammary cancer 25 (38.4%) followed by Luminal A type in 14 (21.5%) of cases, Luminal B type in 11 (16.9%) cases and triple-negative in 15 (23.07%) cases.